Abstract | OBJECTIVE: BACKGROUND: METHODS: This study was a prospective, cross-sectional, case-controlled. We measured the serum sLOX-1 levels in 37 restless legs syndrome patients and 38 controls. RESULTS: Serum sLOX-1 level was significantly lower in the patient group. The two groups were similar in glucose, HbA1c, creatinine, LDL cholesterol, TG, HDL, total protein, albumin, AST, ALT, GGT, ALP, HGB, HCT, MCV, transferrin saturation rate (TSR), ferritin, CRP, TSH, FT4, FT3, B12, and folic acid levels. Also the two groups were similar with respect to age at menarche, number of previous births, number of abortions and/or curettage, total duration of breastfeeding, percentage of patients in menopause, and age at menopause. CONCLUSION: Our results may suggest a lower atherosclerotic risk among RLS patients as compared to the general population (Tab. 3, Ref. 33).
|
Authors | G Halac, E Kilic, M A Cikrikcioglu, K Celik, A Toprak-Erek, S Keskin, I Gultepe, R S Celik, N Ozaras, A Yildiz, S Aydin, O Akan, C Karatoprak, Y Sekin, T Asil |
Journal | Bratislavske lekarske listy
(Bratisl Lek Listy)
Vol. 117
Issue 6
Pg. 316-20
( 2016)
ISSN: 0006-9248 [Print] Slovakia |
PMID | 27546362
(Publication Type: Journal Article)
|
Chemical References |
- OLR1 protein, human
- Scavenger Receptors, Class E
|
Topics |
- Adult
- Aged
- Atherosclerosis
(blood)
- Case-Control Studies
- Cross-Sectional Studies
- Female
- Humans
- Middle Aged
- Prospective Studies
- Restless Legs Syndrome
(blood)
- Scavenger Receptors, Class E
(blood)
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|